EP3102237

COMBINATION OF A PD-1 ANTAGONIST AND AN IDO1 INHIBITOR FOR TREATING CANCER

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    3.2.2015
  • EP published:
    2.12.2020
  • EP application number:
    15746743.2
  • Max expiry date:
    2.2.2035
  • Title:
    COMBINATION OF A PD-1 ANTAGONIST AND AN IDO1 INHIBITOR FOR TREATING CANCER

Timeline

Today
3.2.2015EP application
2.12.2020EP Publication

Owner

  • Name:
    Incyte Corporation
  • Address:
    1801 Augustine Cut-Off, Wilmington, DE 19803, US
  • Name:
    Merck Sharp & Dohme Corp.
  • Address:
    126 East Lincoln Avenue, Rahway, NJ 07065-0907, US

Inventor

  • Name:
    LEOPOLD, Lance
  • Address:
    Wilmington, Delaware 19803, US
  • Name:
    KAUFMAN, David
  • Address:
    North Wales, Pennsylvania 19454-1099, US

Priority

  • Number:
    201461935714 P
  • Date:
    4.2.2014
  • Country:
    US

Classification

  • Categories:
    A61K 31/4245, A61K 39/395, A61K 45/06, A61P 35/00

Upload documents